These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10990411)

  • 1. A concise and efficient route to 2alpha-(omega-hydroxyalkoxy)-1alpha,25-dihydroxyvi tam in D3: remarkably high affinity to vitamin D receptor.
    Kittaka A; Suhara Y; Takayanagi H; Fujishima T; Kurihara M; Takayama H
    Org Lett; 2000 Aug; 2(17):2619-22. PubMed ID: 10990411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionalization at C-12 of 1alpha,25-dihydroxyvitamin D(3) strongly modulates the affinity for the vitamin D receptor (VDR).
    González-Avión XC; Mouriño A
    Org Lett; 2003 Jun; 5(13):2291-3. PubMed ID: 12816431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and efficient synthesis of 2 alpha-(omega-hydroxyalkoxy)-1 alpha,25-dihydroxyvitamin D3 Analogues, including 2-epi-ED-71 and their 20-epimers with HL-60 cell differentiation activity.
    Saito N; Suhara Y; Kurihara M; Fujishima T; Honzawa S; Takayanagi H; Kozono T; Matsumoto M; Ohmori M; Miyata N; Takayama H; Kittaka A
    J Org Chem; 2004 Oct; 69(22):7463-71. PubMed ID: 15497970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluations of A-ring isomers of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3.
    Ikeda M; Takahashi K; Dan A; Koyama K; Kubota K; Tanaka T; Hayashi M
    Bioorg Med Chem; 2000 Aug; 8(8):2157-66. PubMed ID: 11003160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of 2α-(tetrazolylethyl)-1α,25-dihydroxyvitamin D3 as a high affinity ligand for vitamin D receptor.
    Matsuo M; Hasegawa A; Takano M; Saito H; Kakuda S; Takagi K; Ochiai E; Horie K; Takimoto-Kamimura M; Takenouchi K; Sawada D; Kittaka A
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():201-3. PubMed ID: 24036313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric catalytic ene-cyclization approach to 2-fluoro-19-nor-1,25-dihydroxyvitamin D(3) A-ring analog with significant transactivation activity.
    Mikami K; Ohba S; Ohmura H; Kubodera N; Nakagawa K; Okano T
    Chirality; 2001 Jul; 13(7):366-71. PubMed ID: 11400190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and metabolic studies of 1α,2α,25-, 1α,4α,25- and 1α,4β,25-trihydroxyvitamin D3.
    Takano M; Sawada D; Yasuda K; Nishikawa M; Takeuchi A; Takagi K; Horie K; Reddy GS; Chen TC; Sakaki T; Kittaka A
    J Steroid Biochem Mol Biol; 2015 Apr; 148():34-7. PubMed ID: 25263656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, metabolism, and biological activity of 2-[3-(tetrazolyl)propyl]-1α,25-dihydroxy-19-norvitamin D
    Takano M; Yasuda K; Higuchi E; Tohyama E; Takeuchi A; Sakaki T; Kittaka A
    J Steroid Biochem Mol Biol; 2016 Nov; 164():40-44. PubMed ID: 26232635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concise synthesis and biological activities of 2alpha-alkyl- and 2alpha-(omega-hydroxyalkyl)-20-epi-1alpha,25-dihydroxyvitamin D3.
    Honzawa S; Suhara Y; Nihei K; Saito N; Kishimoto S; Fujishima T; Kurihara M; Sugiura T; Waku K; Takayama H; Kittaka A
    Bioorg Med Chem Lett; 2003 Oct; 13(20):3503-6. PubMed ID: 14505658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of 22-iodo- and (E)-20(22)-dehydro analogues of 1alpha,25-dihydroxyvitamin D3.
    Sicinski RR; DeLuca HF
    Bioorg Med Chem; 1999 Dec; 7(12):2877-89. PubMed ID: 10658592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 2-alkyl-1alpha,25-dihydroxy-19-norvitamin D3: efficient synthesis with Julia olefination, evaluation of biological activity and development of new analyzing system for co-activator recruitment.
    Arai MA; Kittaka A
    Anticancer Res; 2006; 26(4A):2621-31. PubMed ID: 16886672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the subdomain in the nuclear receptor for the hormonal form of vitamin D3, 1 alpha,25-dihydroxyvitamin D3, vitamin D receptor, that is covalently modified by an affinity labeling reagent.
    Swamy N; Kounine M; Ray R
    Arch Biochem Biophys; 1997 Dec; 348(1):91-5. PubMed ID: 9390178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient and versatile synthesis of novel 2alpha-substituted 1alpha,25-dihydroxyvitamin D(3) analogues and their docking to vitamin D receptors.
    Suhara Y; Nihei KI; Kurihara M; Kittaka A; Yamaguchi K; Fujishima T; Konno K; Miyata N; Takayama H
    J Org Chem; 2001 Dec; 66(26):8760-71. PubMed ID: 11749604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-6 functionalized analogs of 25-hydroxyvitamin D3 and 1alpha,25-dihydroxyvitamin D3: synthesis and binding analysis with vitamin D-binding protein and vitamin D receptor.
    Addo JK; Swamy N; Ray R
    Steroids; 1999 Apr; 64(4):273-82. PubMed ID: 10399884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential interaction of 1alpha,25-dihydroxyvitamin D3 analogues and their 20-epi homologues with the vitamin D receptor.
    Liu YY; Collins ED; Norman AW; Peleg S
    J Biol Chem; 1997 Feb; 272(6):3336-45. PubMed ID: 9013574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of new aromatic (C17-C20)-locked side-chain analogues of calcitriol (1alpha,25-dihydroxyvitamin D(3)).
    Fernández-Gacio A; Vitale C; Mouriño A
    J Org Chem; 2000 Oct; 65(21):6978-83. PubMed ID: 11031019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of the CYP24A1 major metabolite of 2α-[2-(tetrazol-2-yl)ethyl]-1α,25-dihydroxyvitamin D
    Takano M; Yasuda K; Tohyama E; Higuchi E; Sakaki T; Kittaka A
    J Steroid Biochem Mol Biol; 2017 Oct; 173():75-78. PubMed ID: 27923594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity labeling of the 1 alpha,25-dihydroxyvitamin D3 receptor.
    Ray R; Swamy N; MacDonald PN; Ray S; Haussler MR; Holick MF
    J Biol Chem; 1996 Jan; 271(4):2012-7. PubMed ID: 8567652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further synthetic and biological studies on vitamin D hormone antagonists based on C24-alkylation and C2alpha-functionalization of 25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactones.
    Saito N; Matsunaga T; Saito H; Anzai M; Takenouchi K; Miura D; Namekawa J; Ishizuka S; Kittaka A
    J Med Chem; 2006 Nov; 49(24):7063-75. PubMed ID: 17125259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and testing of 2alpha-modified 1alpha,25-dihydroxyvitamin D(3) analogues with a double side chain: marked cell differentiation activity.
    Suhara Y; Kittaka A; Kishimoto S; Calverley MJ; Fujishima T; Saito N; Sugiura T; Waku K; Takayama H
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3255-8. PubMed ID: 12392726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.